Herbal
gums and mucilage as excipients for Pharmaceutical
Products
Dev Raj Sharma1*, Amit Sharma2, Ankaj
Kaundal1, Puneet Kumar Rai3
1Asst. Professor, Department
of Pharmaceutics, Laureate Institute of Pharmacy Kathog,
HP
1HOD, Pharmacy Practice, ISF
College of Pharmacy Moga, Panjab
3Asst. Professor, Department
of Pharmacognosy, Laureate Institute of Pharmacy Kathog,
HP
*Corresponding Author E-mail: rajandev5655@gmail.com
ABSTRACT:
There are number
of synthetic polymers are available in market for pharmaceutical formulation ,
but these synthetic polymers have certain disadvantages such as high cost, toxicity, environmental pollution
during synthesis, non-renewable sources, side effects, and poor patient
compliance. Because of these disadvantages natural polymers such as natural
gums and mucilage are preferred to semi synthetic and synthetic excipients because of the following advantages :such as:
low cost and natural origin, free from side effects, biocompatible and
bio-acceptable, renewable source, environmental friendly processing, local
availability etc. Natural gums and mucilages are available in
nature freely. These natural gums and mucilages were
successfully used in various dosage forms.
KEYWORDS: Mucilage, Gums, Biocompatible.
INTRODUCTION:
In recent years, plant derived polymers have
tremendous interest due to their diverse pharmaceutical applications such as diluent, binder, disintegrant in tablets, thickeners in oral liquids,
protective colloids in suspensions, gelling agents in gels and bases in
suppository.[1] they are also
used in cosmetics, Textiles, paints and paper-making.[2] Gums are abnormal products, resulting from pathological conditions
brought about either by injury or by adverse conditions of growth and usually
formed by changes in existing cell wall while, mucilage are generally normal
product of metabolism, formed within the cell
and are produced without injury to the plant.[3] Natural gums can
also be modified to meet the requirements of drug delivery systems and thus can
compete with the synthetic excipients available in
the market.[4]
Gum and mucilage
Gums readily dissolve in water, whereas, mucilage form slimy masses.
Gums are pathological products, whereas mucilages are
physiological products. [5] Acacia, tragacanth,
and guar gum are examples of gums while mucilages are
often found indifferent parts of plants. For example, in the epidermal cells of
leaves (senna), in seed coats (linseed, psyllium), roots (marshmallow), barks (slippery elm) and
middle lamella (aloe)[6].
The plant based polymers have been studied for their application in different
pharmaceutical dosage forms like matrix controlled system, film coating agents,
buccal films, microspheres, nanoparticles,
viscous liquid formulations like ophthalmic solutions, suspensions, implants
and their applicability and efficacy has been proven . These have also been
utilized as viscosity enhancers, stabilisers, disintegrants,
solubilisers, emulsifiers, suspending agents, gelling
agents, bioadhesives and binders [7, 8].
Advantages of
natural gums and mucilages in pharmaceutical sciences
[9-10]
The following are a number of the advantages of natural plantbased
materials.
1.
BiodegradableNaturally available
biodegradable polymers are produced by all living organisms. They represent
truly renewable source and they have no adverse impact on humans or
environmental health (e.g., skin and eye irritation).
2.
Biocompatible and non-toxicchemically, nearly
all of these plant materials are carbohydrates composed of repeating sugar (monosaccharides) units. Hence, they are non- toxic.
3.
Low costit is always cheaper to use
natural sources. The production cost is also much lower compared with that for
synthetic material. India and many developing countries are dependent on
agriculture.
4.
Environmental-friendly processingGums and mucilages from different sources are easily collected in
different seasons in large quantities due to the simple production processes
involved.
5.
Local availability (especially in
developing countries) In
developing countries, governments promote the production of plant like guar gum
and tragacanth because of the wide applications in a
variety of industries.
6.
Better patient tolerance as well as public
acceptance There is less chance of side and adverse effects with natural
materials compared with synthetic one. For example, PMMA, povidone.
7. Edible
sourcesMost gums and mucilages are obtained from
edible sources.
Disadvantages
of natural gums and mucilages [9-10]
1.
Microbial contamination The equilibrium
moisture content present in the gums and mucilages is
normally 10% or more and, structurally, they are carbohydrates and, during
production, they are exposed to the external environment and, so there is a
chance of microbial contamination. However, this can be prevented by proper
handling and the use of preservatives.
2.
Batch to batch variationSynthetic
manufacturing is a controlled procedure with fixed quantities of ingredients,
while the production of gums and mucilages is
dependent on environmental and seasonal factors.
3.
Uncontrolled rate of hydrationDue to differences in the collection of natural
materials at different times, as well as differences in region, species, and
climate conditions the percentage of chemical constituents present in a given
material may vary. There is a need to develop suitable monographs on available
gums and mucilages.
4.
Reduced viscosity on storageNormally, when
gums and mucilages come into contact with water there
is an increase in the viscosity of the formulations. Due to the complex nature
of gums and mucilages (monosaccharides
to polysaccharides and their derivatives), it has been found that after storage
there is reduced in viscosity.
Classification
of gums and mucilages [11-15]
Gums and mucilages are present in high
quantities in a varities of plants, animals,
seaweeds, fungi and other microbial sources, where they perform a number of
structural and metabolic functions; plant sources provide the largest amounts.
The different available gums and mucilages can be
classified as follows:-
1. According to the charge
A.
Non-ionic
seed gums: guar, locust bean, tamarind, xanthan, amylose, arabinans, cellulose, galactomannans.
B.
Anionic gums: arabic,
karaya, tragacant, gellan, agar, algin, carrageenans, pectic acid.
2. According to the source
A.
Marine origin/algal (seaweed) gums: agar, carrageenans, alginic acid, laminarin.
B.
Plant origin:
·
Shrubs/tree exudatesgum arabica, gum ghatti, gum karaya, gum tragacanth, khaya and albizia gums.
·
Seed gumsguar gum, locust bean gum,
starch, amylose, cellulose.
·
Extractspectin, larch gum
·
Tuber and rootspotato starch.
C.
Animal origin: chitin and chitosan, chondroitin sulfate, hyaluronic acid.
D.
Microbial origin (bacterial and fungal): xanthan, dextran, curdian, pullulan, zanflo, emulsan, Bakers yeast glycan, schizophyllan, lentinan, krestin, scleroglucan.
3. Semi-synthetic
A.
Starch derivativeshetastarch, starch acetate, starch phosphates.
B. Cellulose
derivativescarboxy methyl cellulose (CMC), hydroxy ethylcellulose, hydroxypropyl methylcellulose (HPMC), methylcellulose (MC),
microcrystalline cellulose (MCC).
4. According to shape
A.
Linear: algins, amylose, cellulose, pectins.
B.
Branched:
a.
Short branchesxanthan,
xylan, galactomanan.
b.
Branch-on-branchamylopectin, gum arabic, tragacanth.
5. According to manomeric units
in chemical structure
A.
Homoglycansamylose, arabinanas, cellulose;
B.
Diheteroglycans algins, carragennans, galactomannans;
C.
Tri-heteroglycansarabinoxylans, gellan, xanthan;
D.
Tetra-heteroglycansgum arabic, psyllium seed gum;
E.
Penta-heteroglycansghatti gum, tragacanth.
Natural gums and mucilages
are use in the pharmaceutical sciences.
1.
Almond Gum: Almond gum is obtained from the tree Prunus communis which is a water
soluble gum extrudes from the wounds on almond trees. The constitution of
almond gum includes aldobionic acid, L-arabinose, L-galactose, D-mannose
etc. It contains different components which have emulsifier, thickener,
suspending pharmaceutical, adhesive, glazing agent and stabilizer. Gum obtained
from Almond as a binder in tablet formulations was studied .[16]
2.
Neem Gum: Neem gum is obtained from the trees of Azadirachta indica belongs
to the family Meliaceae. Each and every part of the
tree (bark, leaves, root and fruit) serves a certain purpose. Neem gum contains mannose, glucosamine, arabinose,
galactose, fucose, xylose and glucose [17]. In a study Neem gum used as a binder in pharmaceutical dosage forms[18].
A sustained release matrix tablets of Nimesulide
using the fruit mucilage of Azadirachta indica was studied [19].
3.
Aloe mucilage: Aloe mucilage is obtained from the leaves of Aloe barbadensis Miller.
Aloe vera leaves and the exudate
arising from the cells adjacent to the vascular bundles. The bitter yellow exudate contains 1, 8 dihydroxy anthraquinone derivatives and their glycosides[20].
Many investigators have identified partially acetylated mannan
(or acemannan) as the primary polysaccharide of the
gel, while others found pectic substance as the
primary polysaccharide. Other polysaccharides such as arabinan
, arabinorhamnogalactan, galactan,
galactogalacturan, glucogalactomannan,
galactoglucoarabinomannan and glucuronic
acid containing polysaccharides have been isolated from the Aloe vera inner leaf gel part[21]. A controlled delivery
system of glibenclamide using aloe mucilage was
studied [22].
4.
Cashew Gum: Cashew gum is the exudate
from the stem bark of Anacardium occidentale Linn
(family, Anarcardiaceae). Cashew gum is chemically
composed of 61 % galactose, 14 % arabinose,
7 % rhamnose, 8 % glucose, 5% glucuronic
acid and < 2 % other sugar residues, while hydrolysis of the gum yields L‐arabinose, L‐rhamnose, D‐galactose and glucuronic acid The gum
has a highly branched galactan framework comprising
of chains of (1→3) ‐ linked βD‐galactopyranosyl units interspersed with β‐(1→ 6) linkages[23] . Gelling
potentials of a natural gum obtained from plant Anacardium
occidentale was studied [24]. Cashew gum
mucilage used as a binder for the preparation of metronidazole
tablet formulations[25].A controlled delivery system was developed
for diclofenac sodium using Cashew nut tree gum, HPMC
and Carbopol[26] .
5.
Fenu Greek mucilage: Trigonella foenum-graceum,
commonly known as Fenugreek, is an herbaceous plant of the leguminous family.
Fenugreek seeds contain a high percentage of mucilage (a natural gummy
substance present in the coatings of many seeds). Although it does not dissolve
in water, mucilage forms a viscous tacky mass when exposed to fluids. Like
other mucilage containing substances, fenugreek seeds swell up and become slick
when they are exposed to fluids [27]. Ability of the husk to form mucilage,
its binding properties in solid dosage forms were studied [28].
Mucilage derived from the seeds of fenugreek evaluated as a matrix formulation
containing propranolol hydrochloride. Methocel K4M was used as a standard controlled release
polymer for comparison [29]. Gelling potentials of Fenugreek
mucilage was evaluated [30].
6.
Locust Bean Gum: Locust bean gum is a high molecular weight (3,10,000)
hydro colloidal polysaccharide derived from the endosperm of the seed of Ceratonia siliqua Linn (Family- Leguminosae). The gum contains 88% D-galacto-Dmannoglycan, 4% pentan, 6% of
proteins, 1% cellulose and 1% ash. Plant seed galactomannan,
composed of a 1-4 linked β-D-mannan backbone
with 1- 6- linked α-D-galactose side groups
[31]. This neutral polymer is only slightly soluble in cold water; it
requires heat to achieve full hydration, solubilization
and maximum viscosity [32]. Superdisintegrant
property of nimesulide orodispersible tablets
contains locust bean gum was prepared and evaluated against standard superdisintegrant i.e. crosscarmellose
sodium [33]. A controlled delivery system for propranolol
hydrochloride using the synergistic activity of LBG and xanthan
gum was studied [34]. Locust bean gum investigated as a compression
coat applied over core tablets as a suitable carrier for colonic drug delivery
[35].
7.
Khaya gum: Khaya gum is a
polysaccharide obtained from the incised trunk of the tree Khaya grandifoliola (family
Meliaceae). It is known to contain highly branched
polysaccharides consisting of D galactose, L-rhamnose, Dgalacturonic acid and
4-O 60 methyl-D-glucoronic acid [36].Khaya gum has been successfully evaluated khaya gum as a controlled realese
agent in comparision with hydroxypropylmethyl
cellulose (HPMC) using paracetamol (water soluble)
and indomethacin (water insoluble) as model drugs[37].
Khaya and albizia gums were
evaluated as compression coatings for target drug delivery to the colon using indomethacin and paracetamol as
model drugs [38]. Suspending properties of khaya
senegalensis gum comparatively with those of Acacia sieberiana and Acacia senegal
gums was studied in paracetamol suspension [39].
Colon specificity of the khaya gum/guar gum was
investigated with the drugs domperidone and budesonide, and the results were compared with well
established guar gum[40].
8.
Tara Gum:
Tara gum is obtained from the endosperm of seed of Caesalpinia spinosa,
commonly known as tara. It is small tree of the
family Leguminosae or Fabaceae.
Tara gum is a white, nearly odorless powder. The
major component of the gum is a galactomannan polymer
similar to the main components of guar and locust bean gums, consist of a
linear main chain of (1-4)-β-D-mannopyranose
units with α-D-galactopyranose units attached by
(1-6) linkages. The ratio of mannose to galactose in tara gum is 3:1, produce highly viscous solutions, even at
1% concentration [41]. The use of tara gum
as a controlled release carrier in the formulation of gastroretentive
controlled release tablets [42] and emulsions[43] for
drugs like metformin hydrochloride, ciprofloxacin
hydrochloride was studied.
9.
Phoenix Mucilage: Phoenix mucilage is obtained from the dried fruit of Phoenix dactylifera was
brown colour date fruit composed of amino acids and proteins, carbohydrates,
fatty acids, salts and minerals, and dietary fibre . Carbohydrates make up to
44 - 88% of the fruit which include mainly reducing sugars such as fructose,
sucrose, mannose, glucose and maltose in addition to small amounts of
polysaccharides such as pectin (0.5 - 3.9%), starch and cellulose . The protein
content is approximately 2.3-5.6% with 23 amino acids which include alanine, aspartic acid, serine, glutamic
acid, threonine, proline and
glycine .Binding properties of date palm mucilage was
successfully evaluated[44].
10. Hibiscus Mucilage: Hibiscus rosasinensis Linn of the Malvaceae family
is also known as the shoe flower plant, China rose, and Chinese hibiscus.
Mucilage of Hibiscus rosasinensis contains L-rhamnose, D-galactose, D-galactouronic acid
and D-glucuronic acid [45]. In a study the
use of mucilage for the development of sustained release tablet [46].Mucilage
of Hibusccus subjected to toxicity studies for its
safety and preformulation studies for its suitability
as a disintegrating agent [47].
11. Moi Gum: Moi
gum is obtained from Lannea coromandelica (Houtt.) Merrill (Anacardiaceae). Moi gum is yellowish white colour in fresh and on drying
becomes dark. Gum ducts are present in leaves, stems and fruits and aremost abundant in the bark of the stem[48]
.The roots contain cluytyl ferulate;
heartwood gives lanosterol; bark,dlepi-
catechin and (+)-leucocyanidin;
flowers and leaves, ellagic acid, quercetin
and quercetin-3 arabinoside. Flowers also contain iso-quercetin and morin. Leaves
in addition contain beta-sitosterol, leucocyanidin and leucodelphinidin[49].
Natural gum moi was successfully evaluated as
microencapsulating agent and release rate controlling material for lamivudine. Microspheres were prepared by solvent
evaporation technique [50].
12. Isapghula Mucilage:
Psyllium seed husks, also known as ispaghula, isabgol, or simply as psyllium, are portions of the seeds of the plant Plantago ovata,
(genus plantago), a native of India and Pakistan. Gel
forming fraction of the alkaliextractable
polysaccharides is composed of arabinose, xylose and traces of other sugars. They are soluble in
water, expanding and becoming mucilaginous when wet. Seeds are used
commercially for the production of mucilage. It is white fibrous material,
hydrophilic in nature and forms a clear colourless mucilaginous gel by
absorbing water. Psyllium seed husk has been
successfully evaluated as binder, disintegrant,
release retardant [51] and also pH sensitive novel hydrogels using N, N methylenebisacrylamide
as crosslinker and ammonium persulfate
(APS) as initiator for model drugs (tetracycline hydrochloride, insulin and
tyrosine), for colon specific drug delivery systems [52].
13. Grewia Gum: Grewia
Gum is a polysaccharide derived from the inner bark of the edible plant Grewia mollis,
(family Tiliaceae). The plant is a savanna shrub that grows wildly but is usually cultivated.
The polysaccharide gum consists of glucose and rhamnose
as the main monosaccharide components and galacturonic
acid as the main sugar acid[53]. The leaves and bark of the plant
contain mucilage. Physicochemical properties, surface chemistry, molecular
weight, thermal properties and Compositional analysis of the gum was carried
out[54]. Binder properties of Grewia gum
was evaluated using paracetamol as a model drug. Compressional properties of the formulations were analyzed
using Heckle and Kawakita equations[55].
Single polymer matrix tablets of cimetidine were
formulated [56]. Potentials of grewia gum
were evaluated as a film coating agent using praziquantel
as a model drug [57].
14. Mango Gum: Mango gum is a dried gummy exudate
polysaccharide obtained from the bark of Mangifera indica,
belongs to the family Anacardiaceae. Physical,
thermal, sorption and functional properties of a mango gum were characterized.
The results obtained in this study establish the fundamental characteristics of
mango gum [58]. Gum of Mangifera indica (mango) as a tablet binder employing paracetamol as a model drug[59],resin of mangifera indica (mango) as a
tablet retardant polymer in the formulation development of sustained release of
drugs, employing diclofenac sodium as a model drug
was studied[60].Mouth dissolving tablets of metformin
hydrochloride was prepared using mango gum powder as disintegrant[61].
15. Terminalia Gum: Terminalia gum exudates obtained from the incised trunk of the
tree Terminalia randii
(Family Combretaceae). The
bark is smooth with beige to grey brown colour, with yellowish or beige slash
while the stem is pubescent.Extracts of the stem and
bark of Terminalia randii
are used in the treatment of dysentery, diarrhea, hemorrhoids and wounds.Gum
exudates obtained from Terminalia randii has
been evaluated as binding agent in carvedilol tablet
formulations and compared with standard binders like polyvinylpyrrolidone
(PVP) and corn starch[62].
16. Honey Locust Gum: It is known botanically as Gleditsia triacanthos, and
belongs to the order Leguminosea (suborder Mimoseae). The gum is obtained from the seeds of the plant.
The seed contains proteins, fats, carbohydrates and fibers.
Honey locust gum was used to produce matrix tablets at different concentrations
(5% and 10%) by wet granulation method using theophylline
as a model drug [63].
17. Cordia Mucilage: Cordia
Mucilage is obtained from raw fruits of Cordia Obliqua,
willed family Boraginaceae. The mucilaginous
substance of the fruit used as gum an expectorant and is effective in treating
the disease of the lungs and the raw gum can be used beneficially in
gonorrhoea. Efficacy of cordia obliqua fruit
mucilage as pharmaceutical excipient as tablet binder
and emulsifier was studied. [64].
18. Gellan Gum: Gellan
gum (commercially available as GelriteTM or Kelcogel TM) is an anionic deacetylated
exocellular polysaccharide secreted by Pseudomonas elodea with a tetrasaccharide
repeating unit of one -l-rhamnose, one d-glucuronic acid and two d-glucose. While native gellan contains also two acyl substituents on the same glucose molecule[65],
in the commercial products the acyl groups are completely
removed. Gellan, as well as the commercial products,
is capable of gelation in the presence of mono- and
divalent ions[66]. In a study, aqueous solutions of gellan gum form gels on warming to body temperature and in
the presence of cations[67]. In another
study gellan gum evaluated as a disintegrating agent [68].
19. Albizia Gum: Albizia gum is obtained from the incised trunk of the tree Albizia zygia,
family Leguminosae and is shaped like round elongated
tears of variable colour ranging from yellow to dark brown. It consists of
β-1 3-linked D-galactose units with some ί1-6-linked D-galactose
units. The genus Albizia containing some twenty-six
species is a member of the Mimosaceae, a family which
also includes the gum-bearing genera Acacia and Prosopis.
Only two species of Albizia, A. zygia
and A. sassa, are however, known to produce gum [69].
Albizia gum is evaluated as a binding agent in tablet formulations in
comparison with gelatin BP[70]. Albizia gum has been successfully evaluated as a suspending
agent in Sulphadimidine suspension as compared to the
relatively common natural agents as Acacia, Tragacanth
and Gelatin[71]. A comparision
study was carried out to assess the in vitro behaviour of tablet cores coated with novel films of albizia, albizia/khaya and albizia/HPMC [72].
20. Tamarind Seed Polysaccharide: Tamarind seed polysaccharide obtained from the seed
kernel of Tamarindus indica,
possesses properties like high viscosity, broad pH tolerance, noncarcinogenicity, mucoadhesive
nature, and biocompatibility. The tamarind seed polysaccharide constitutes
about 65% of the tamarind seed components [73]. It is a branched
polysaccharide with a main chain of -d-(1,4)-linked glucopyranosyl
units, and that a side chain consisting of single d-xylopyranosyl
unit attached to every second, third, and fourth d-glucopyrnosyl
unit through an -d-(1,6) linkage. One d-galatopyranosyl
unit is attached to one of the xylopyranosyl units
through a -d-(1, 2) linkage[74]. In a stud tamarind seed
polysaccharide obtained from tamarind kernel powder and this was utilized in
the formulation of matrix tablets containing Diclofenac Sodium by wet
granulation technique and evaluated for its drug release characteristics[75].
Another study on Pilocarpine in-situ gelling solution
based on alginate along with novel bioadhesive
tamarind gum[76]. Potentials of tamarind seed polysaccharide to act
as a biodegradable carrier for colon specific drug delivery was studied[77].
21. Moringa Oleifera Gum: Moringa oleifera is a
small genus of quick growing tree distributed in india.
The stem of the tree exudates a gum which is initially white in colour but
changes to reddish brownish black on exposure. It is sparingly soluble in water
but swells in contact with water giving a highly viscous solution .It is a polyuronide constituting of arabinose,
galactose and glucoronic
acid in the preparation of 10:7:2,rhamnose present in traces[78]. In
study potentials of moringa olifera gum as
gelling agent [79], binder, release retardant in tablet
formulations, and the effect of calcium sulpha dehydrate, lactose diluents on
release of propronolol hydrochloride [80].
Another study moringa gum used as a disintegrant[81].
22. Gum Copal: Gum copal is a natural resinous material of plant Bursera bipinnata (family
Burseraceae).Copal, a resinous material, is obtained
from the plants of Araucariaceae and Caesalpinaceae, a subfamily of Leguminoaceae
. Copal resin (CR) contains agathic acid, a diterpenoid and related lobdane
compounds along with cis-communic acid, trans-communic acid, polycommunic acid,
sandaracopimaric acid, agathalic
acid, monomethyl ester of agathalic
acid, agatholic acid and acetoxy
agatholic acid. CR obtained from leguminoaceae
family contains copalic acid, pimaric
acid, isopimaric acid, dehydro-dehydroabietic
acid, dehydroabietic acid and abietic
acid[82]. Copal gum has been evaluated as matrix-forming material
for sustaining the drug delivery. In an independent study copal resin as a film
forming agent. Films showed good swelling property. It was concluded that it
can be used as a coating material for sustained release and colon targeted drug
delivery [83].
23. Bhara Gum: Bhara Gum is a yellowish natural gum of plant Terminalia bellerica belonging
to family Combretaceae. Bahara
gum, extracted from the bark of Terminalia bellerica, is a
waste material. Main chemical constitutents are
tannins which mainly include ί- sitosterol, gallic acid, ellagic acid, ethyl gallate, galloyl glucose and chebulaginic acid[84]. A new sustained release
microencapsulated drug delivery system employing bhara
gum has been proposed .The microcapsules were formulated by ionic gelation technique using famotidine
as the model drug [85].
24. Mimosa Mucilage: Mimosa pudica, commonly known as sensitive plant belongs to family Mimosaceae. Mucilage of M. pudica
is obtained from seeds, which is composed of d-xylose
and d-glucuronic acid. Mimosa seed mucilage hydrates
and swells rapidly on coming in contact with water. A controlled delivery
system for diclofenac sodium using Mimosa seed
mucilage was studied [86].
25. Olibanum Gum: Olibanum gum is a dried, gummy exudation obtained from various
species of burseraceae trees.Its
composition and chemical characteristics
depends on its three principal origins : Aden/Somalia, Eritrea, and India which
contains approximately 5-9% oil content, 13-17% resin acids, 20-30%
polysaccharides, 40-60% boswellic acid. Gum olibanum is used as an anti-inflammatory remedy and recent studies have found positive influence of olibanu-m on rheumatism [87]. Ambroxol hydrochloride hydrophilic matrix sustained release
tablet employing gum olibanum and the sustained release behavior
of the fabricated tablets was investigated[88]. Effect of gums as
binders namely acacia, tragacanth, guar gum, gum karaya
and gum olibanum on the disintegration, dissolution
rate and other qualities of Ziprasidone tablets was studied [89]. Olibanum resin was evaluated as a microencapsulating agent.
Olibanum resin coated microcapsules of indomethacin were prepared by an industrially feasible
emulsification-solvent evaporation method and the microcapsules were
investigated [90].
26. Terminalia Gum: Terminalia gum exudates obtained from the incised trunk of the
tree Terminalia randii
(Family Combretaceae). The
bark is smooth with beige to grey brown colour, with yellowish or beige slash
while the stem is pubescent.Extracts of the stem and
bark of Terminalia randii
are used in the treatment of dysentery, diarrhea, hemorrhoids and wounds.Gum
exudates obtained from Terminalia randii has
been evaluated as binding agent in carvedilol tablet
formulations and compared with standard binders like polyvinylpyrrolidone
(PVP) and corn starch[91].
CONCLUSION:
·
The present review of the literature
shows the release behavior of natural polymers, gums and mucilages.
Therefore, in the years to come, these act as herbal excipients
in drug delivery systems.
·
Natural polymers play an important role in the
drug delivery. While selecting polymers care has to be taken regarding its
toxicity and compatibility. By this review, author wanted to explore natural
polymers which can be a good substitute for the synthetic polymers.
·
Now-a-days natural polymers play a very
important role almost in all kind of formulations. The pharmaceutical
scientists have achieved a great success in developing the most therapeutic
systems with suitable natural polymers. The use of natural gums for
pharmaceutical applications is attractive because they are economical, readily
available, non-toxic, and capable of chemical modifications, potentially
biodegradable and with few exceptions, also biocompatible. They have a major
role to play in pharmaceutical industry. Therefore, in the years to come, there
is going to be continued interest in the natural excipients
to have better materials for drug delivery systems.
·
In
addition to conventional pharmaceutical excipients as
bulking agents, substance used for masking taste/texture or as a substance use
to aid during manufacturing process, Novel excipients
offer broad range of additional properties suitable to preserve the integrity
of active constituents of the formulation and enhances its
self life. The synthetic polymers can be designed or modified as per
requirement of the formulation; by altering polymer characteristics and on the
other hand herbal pharmaceutical excipients are
biocompatible, non toxic, environment friendly and economical. It seems
conceivable that in the near future, kilogram quantities of fusion proteins, fibronectin, poly (lysine), or hemolysin
could become available as off-the-shelf excipients or
as designer excipient kits. Excipients
that have never been used before must pass formidable regulatory requirements
before being incorporated into approved dosage forms.
REFERENCES:
1. Zatz, JL, Kushla
GP, 1989. In: Pharmaceutical dosage forms-Disperse systems, M. M. Reiger and G.S. Banker, Ed; Marcel Dekker Inc., New York,
2: 508.
2. Jania, GK, Shahb
DP, Prajapatia VD, Jainb
VC. Gums and mucilages: versatile excipients
for pharmaceutical formulations, Asian J. Pharmaceutical Sci., 2009; 4(5):
309-323.
3.
Wallis TE. Text Book
of Pharmacognosy. 5th Ed, Published by CBS Publishers And Distributors, Delhi,
India, 2005:465,472. 474-477.
4.
Bhardwaj TR, Kanwar M, Gupta A. Natural gums and modified natural gums
as sustained-release carriers. Drug Dev Ind Pharm 2000; 26: 1025-38.
5.
Qadry JS, Shah.
Pharmacognosy. Ahmedabad, India: B S Shah Prakashan; 2008.
6.
Evans WC, Trease and Evans.
Pharmacognosy.14th edn, Harcourt Brace and Co., Asia
Pvt. Ltd, Singapore.1996; 196, 208, 209, 213-215, 462, 555.
7.
Pandey
R, Khuller GK. Polymer based drug delivery systems
for mycobacterial infections. Curr
Drug Deliv 2004; 1: 195-201.
8.
Chamarthy SP, Pinal R. Plasticizer
concentration and the performance of a diffusion-controlled polymeric drug
delivery system. Colloids Surf. A. Physiochem. Eng
Asp 2008; 331: 25-30.
9.
Kottke KM, Edward MR.
Tablet Dosage Forms. In: Banker GS, Rhodes CT, ed. Modern Pharmaceutics. New
York: Marcel Dekker, Inc. 2002: 287-333.
10.
Aslam A, Parrott E.
Effect of aging on some physical properties of hydrochlorthiazide
tablets. J Pharm. Sci. 1971; 60: 263-266.
11.
Rangari VD. Pharmacognosy
and Phytochemistry. Nashik, India: Career
Publication; 2006.
12.
Wallis TE. Text Book of Pharmacognosy. New Delhi,
India: C B S Publishers and Distributors; 2004.
13.
Mohammed A. Text Book of Pharmacognosy. New Delhi,
India: C B S Publishers and Distributors; 2005.
14.
Ansari SH. Essential of
Pharmacognosy. New Delhi, India: Birla Publications Pvt. Ltd.; 2006.
15.
Sarojini S, Kunam DS, Manavalan R, Jayanthi B. Effect of natural gum as a binder in the
formulation of diclofenac sodium tablets.
International Journal of Pharmaceutical Sciences and Research. 2010; 1(3):
55-60.
16.
Kokate
CK, Purohit AP, Gokhale SB.
Pharmacognosy. 11th ed.; Pune; Nirali
Prakashan; 1999: 498.
17.
Gangurde AB, Malode SS, Bhambar RS. Preliminary Evaluation of Neem
Gum as Tablet Binder. Indian Journal of Pharmaceutical Education and Research
2008; 42(4): 344-347.
18.
Hindustan
AA, Kumar CS, Kumar AB. Fabrication and evaluation of Nimesulide
Azadirachta indica fruit
mucilage based sustained release matrix tablets. International Journal of ChemTech Research 2010; 2(2): 937-941.
19.
Vazquez
B, Avila G, Segura D, Escalante B. Anti-inflammatory activity of extracts from
Aloe vera gel. J Ethnopharmacol
1996; 55: 69-75.
20.
Choi
S, Chung M.H. A review on the relationship between Aloe vera
components and their biologic effects. Semin Integr Med. 2003; 1: 53-62.
21.
Hindustan
AA, Kumar CS, Kumar AB, Reddy AB.
Development and in Vitro Evaluation of Glibenclamide
Aloe barbadensis Miller leaves Mucilage Controlled
Release Matrix Tablets. International Journal of PharmTech
Research. 2010; 2 (2): 1018-1021.
22.
Lima
RDN, Lima JR, Salis CR, Moreira
RA. Cashew tree (Anacardium occidentale L.) exudate gum: a
novel bioligand tool. Biotechnol
Appl Biochem. 2002; 35: 45
53.
23.
Kumar
R, Patil MB, Sachin RP,
Mahesh S. Evaluation of Anacardium occidentale gum as gelling agent in Aceclofenac
Gel. International Journal of PharmTech Research.
2009; 1(3): 695-704.
24.
Kwabena OK, Asantewaa A, Samuel SK.
Physicochemical and binding properties of cashew tree gum in metronidazole tablet formulations. 2010; 2(4):105-109.
25.
Ganesh
GNK, Sureshkumar R , Jawahar
N, Senthil V, Nagasamy DV.
Preparation and Evaluation of Sustained Release Matrix Tablet of Diclofenac
Sodium using Natural Polymer. Journal of Pharmaceutical Sciences and Research.
2010; 2(6): 360-368.
26.
Petropoulos
GA. Fenugreek: The genus Trigonella. In: Petropoulus GA, (Ed.), Botany. London: Taylor and
Francis. 2002; 917.
27.
Nitalikar M, Rama A,Swati PD. Dinesh DM.
Evaluation of fenugreek seed husk as tablet binder. International Journal of Pharma Research and Development. 2010; 2(8): 21-23.
28.
Ali N, Hossein N, Afagh K, Tarifeh S, Hadi V, Ford JL. An In
Vitro Evaluation of Fenugreek Mucilage as a Potential Excipient
for Oral Controlled-Release Matrix Tablet. Drug Dev Ind
Pharm. 2008; 34: 32329.
29.
Gowthamrajan K, Kulkarni GT, Muthukumar A. Evaluation of Fenugreek mucilage as gelling
agent. Int. J. Pharm. Expt., 2002; 3: 16-19.
30.
Dea
ICM, Morrison A. Chemistry and interactions of seed galactomannans.
Adv Carbohydr Chem Biochem. 1975; 31: 242-312.
31.
Jain A,
Gupta Y, Jain SK. Perspectives of Biodegradable Natural Polysaccharides for
Site-Specific Drug Delivery to the Colon. J Pharm Pharmaceut Sci. 2007; 10(1): 86-128.
32.
Malik
K, Arora G, Singh I. Locust bean Gum as Superdisintegrant Formulation and Evaluation of Nimesulide Orodispersible Tablets. Polimery
Medycynie.
2011; 17-28.
33.
Venkatarajua MP, Gowdaa DV, Rajeshb KS, Shivakumara HG. Xanthan and locust bean gum (from Ceratonia
siliqua) matrix tablets for oral controlled delivery
of propranolol hydrochloride. Asian J Pharm Sci. 2007; 2(6): 239-48.
34.
Josephine
Leno J, Vijaya K, Suma R, Raj B. Formulation and
evaluation of compression coated tablets of mesalazine
for colon delivery. International Journal of
PharmTech Research. 2010; 2(1): 535-541.
35.
Aspinall GO, Bhattacharjee AK. Plant
gums of the genus Khaya. Part IV. J Chem Soc. 1970; 36569.
36.
Odeku
OA, Fell JT. Evaluation of khaya gum as a directly
compressible matrix system for controlled release, J.Pharm.
Pharmacol. 2004; 56:136570.
37.
Odeku
OA, Fell JT. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to
the colon. J Pharm Pharmacol.
2005; 57(2):163-68.
38.
Mahmud
HS, Oyi AR, Allagh T.
Evaluation of the suspending properties of khaya senegalensis gum in paracetamol suspensions.
Nigerian Journal of Pharmaceutical Sciences.2009; 8(1):128-134.
39.
Prabhu
P, Satyanarayana D, Koland
M, Nairy HM, Ahmed NR. Investigation of effect of
drug solubility on colon specificity of polysaccharide polymers khaya gum and guar gum. International. Journal of.
Research. Pharma Scope. 2010; 1(3): 345-352.
40.
Final
assessment report: Application A546 Tara Gum As A Food Additive. Food Standards
Australia New Zealand. 2006.
41.
Shin
HJ, Ki MH, Yoon B, An SW, inventors; Chong Kun Dang
Pharmaceutical Corp., assignee. Gastroretentive
controlled release mono matrix tablet. WO/2006/088305.
42.
Zeng
H, Moroni A, Baichwal AR, Goliber PA, Ketsela S, Mcnamara DP, Inventors; Penwest
Pharmaceuticals, Co. , assignee. Controlled- release emulsion compositions.
WO/2007/056424. 2007.
43.
Ngwuluka NC, Idiakhoa BA, Nep EI, Ogaji I, Okafor IS. Formulation and evaluation of paracetamol tablets manufactured using the dried fruit of
Phoenix dactylifera Linn as an excipient.
Research In Pharmaceutical Biotechnology. 2010; 2(3): 25-32.
44.
The
Wealth of India, First Supplement Series (Raw Materials), National Institute of
Science and Communication, CSIR, Volume V: HK, New Delhi, India. 2002: 9192.
45.
Jani
GK, Shah DP. Assessing Hibiscus rosa-sinensis Linn as
an Excipient in Sustained-Release Tablets. Drug
Develop Ind Pharm.
2008; 34 (8): 807 16.
46.
Shah V,
Patel R. Studies on mucilage from hibuscus rosa-sinensis linn as oral disint-egrant. International Journal of Applied
Pharmaceutics. 2010; 2 (1):19-21.
47.
Venkaiah K, Shah J. Distribution, Development and Structure of
Gum Ducts in Lannea coromandelica
(Houtt.) Merril. Annals of
Botany. 1984; 54:175-86.
48.
Khare
CP. Indian medicinal plant An Illustrated Dictionary. New York (USA): Springer
Science. Business Media. 2007:361.
49.
Nayak
BS, Nayak UK, Patro KB,
Rout PK. Preparation and In Vitro Evaluation of Lamivudine
Entrapped MOI Microspheres for Oral Administration. Research J Pharm and Tech.
2008; 1(4):437-41.
50.
Singh
B. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007; 334: 114.
51.
Singh
B, Bala R, Chauhan N. In
vitro release dynamics of model drugs from psyllium
and acrylic acid based hydrogels for the use in colon
specific drug delivery. J Mater Sci Mater Med. 2008;
19: 277180.
52.
Okafor
IS, Chukwu A, Duala K. Somephysicochemical
properties of grewia gum. Nigeria. Journal of Polymer
Science and Technology. 2001; 2(1):161-167.
53.
Elijah
IN, Barbara RC. Characterization of Grewia Gum, a
Potential Pharmaceutical Excipient. Journal of Excipients and Food Chem. 2010; 1(1); 31-40.
54.
Martins
E, Christiana I, Olobayo K. Effect of Grewia gum on the mechanical properties of Paracetamol
tablet formulations. African Journal of Pharmacy and Pharmacology. 2008; 2:
1-6.
55.
Nep
EI, Conway BR. Polysaccharide gum matrix tablets for oral controlled delivery
of Cimetidine. Journal of Pharmacetical
Sciences and Research. 2010; 2(11):708-716.
56.
Ogaji
I, Okafor IS. Potential of Grewia
Gum as Film Coating Agent: Some physicochemical properties of Coated Praziquantel Tablets. International Journal of
Pharmaceutical Research. 2011; 3(2);
16-19.
57.
Singh
AK, Selvam RP, Sivakumar T.
Isolation, characterisation and formulation properties of a new plant gum
obtained from mangifera indica.
International Journal of pharmaceutical and biomedical research. 2010;
1(2):35-41.
58.
Singh
AK, Shingala VK, R. Selvam
RP. Evaluation of mangifera indica
gum as tablet binder. International Journal of PharmTech
Research. 2010; 2(3): 2098-2100.
59.
Shingala VK, Singh AK, Yadav SK.
Design and characterization of Diclofenac sodium tablets containing Mangifera indica resin as release
retardant. International Journal of PharmTech
Research. 2010; 2(3): 2107-2111.
60.
Nayak
RK, Sachin R, Mirtyunjaya
B. Evaluation of disintegrating properties of mangifera
indica. RGUHS journal of pharmaceutical sciences.
2011; 1(1):11-20.
61.
Oluyemisi A. Bamiro, Sinha VR, Kumar R. Characterization and evaluation of Terminalia randii gum as a binder
in carvedilol tablet formulation. Acta
Pharmaceutica Sciencia.
2010; 52: 254-262.
62.
άner
M, Altinkurt T. Evaluation of honey locust (Gleditsia triacanthos Linn.) gum
as sustaining material in tablet dosage forms. IL Farmaco.
2004; 59(7): 567-73.
63.
Dinda
SC, Mukharjee B. Gum cordia
A new tablet binder and emulsifier. Acta Pharmaceutica Sciencia. 2009; 51: 189- 198.
64.
Kuo
MS, Dell A, Mort AJ. Identification and location of L-glyceratel56, an unusual
substituent in gellan gum. Carbohydrate Res 1986;
156: 173-187.
65.
Grasdalen H. Smidsroed O. Gelation of gellan gum. Carbohydr PoZym. 1987; 7:
371-393.
66.
Kubo W,
Miyazaki S, Attwood D. Oral sustained delivery of paracetamol
from in situ-gelling gellan and sodium alginate
formulations. International Journal of Pharmaceutics. 2003; 2:5564.
67.
Antony
PJ, Sanghavi NM. A new disintegrant
for pharmaceutical dosage forms. Drug Dev. Ind. Pharm. 1997; 23: 413-415.
68.
Ashton
WA, Jefferies M, Morley RG, Pass G, Phillips G O, Power DMJ. Physical
properties and applications of aqueous solutions of Albizia
zygia gum. J Sci Food
Agric. 1975; 26: 697704.
69.
Oluwatoyin A, Odeku. Assessment of albizia gum as a binding agent in tablet formulations. Acta Pharm. 2005; 55: 263276.
70.
Mbang
N, Femi-Oyewo, Musiliu O, Adedokun F, Taiwo O. Evaluation of the suspending properties of Albizia zygia gum on sulphadimidine suspension. Tropical Journal of
Pharmaceutical Research. 2004; 3(1): 279-284.
71.
Kwabena O, Emily NA, and Samuel L. Preparation and invitro characteristics of tablet cores coated with albizia, albizia/khaya and albizia/hpmc films. International Journal of Applied Pharmaceutics.
2009; 1(1): 222.
72.
Rao
PS, Srivastava HC., Tamarind in industrial gums. In:
Whistler RL. 2nd ed., Academic Press, New York. 1973; 369-411.
73.
Gidley
MJ, Lillford PJ, Rowlands
DW. Structural and solution properties of tamarind seed polysaccharide,
Carbohydrate Res. 1991; 214: 299-314.
74.
Deveswaran R, Sindhu A, Bharath S, Basavaraj B, Sharon F.
Design and Characterization of Diclofenac sodium tablets containing Tamarind
seed polysaccharide as Release retardant. International Journal of PharmTech Research 2009; 1(2):191-195.
75.
Gilhotra RM, Mathur M, Saroot R, Gilhotra N. Enhancement of miotic
potential of pilocarpine by tamarind gum based
in-situ gelling ocular dosage form. Acta Pharmaceutica Sciencia 2010; 52:
145-154.
76.
Mishra
MU, Khandare NJ. Evaluation of tamarind seed
polysaccharide as abiodegradable carrier for colon
specific drug delivery. International Journal of Pharmacy and Pharmaceutical Sciencesl 2011; 3(1):139-142.
77.
Wealth
of india-raw materials. Council of scientific and
industrial research 1998; 2; 429.
78.
Panda
D, Swain S, Gupta R. Preparation and evaluation of gels from gum moringa olifera. Indian journal
of pharmaceutical sciences2006; 777-780.
79.
Panda
D, Swain S, Gupta R. Esvaluation of gum of moringa olifera as a binder and
release retardant in tablet formulations. Indian journal of pharmaceutical
sciences2008; 614-618.
80.
Patel
BV, Patel D. Study of Disintegrant Property of Moringa Oleifera Gum and its
Comparison with other Superdisintegrants.
International Journal of ChemTech Research2011;
3(3):1119-1124.
81.
Osete-Cortina
L, Domenech-Carbo MT. Analytical characterization of diterpenoid resins present in pictorial varnishes using pyrolysis-gas chromatography-mass spectrometry with on line
trimethylsilylation. J Chromatogr
A 2005; 1065:265-78.
82.
Umekar MJ, Yeole PG. Characterization and evaluation of natural copal
gum-resin as film forming material. Int Journal of
green pharmacy 2008; 2(1):37-42.
83.
The
wealth of India, first supplement series, volume -3: Si-Ty, New Delhi, Dr K S
Krishna Marg; National institute of science
communication, CSIR 1999: 89-137.
84.
Nayak
BS, Nayak UK, Patro KB,
Rout PK. Design and Evaluation of Controlled Release Bhara
Gum Microcapsules of Famotidine for Oral Use.
Research J Pharm and Tech 2008; 1(4):433-36.
85.
Singh
K, Kumar A, Langyan
N, Ahuja M. Evaluation of Mimosa pudica
Seed Mucilage as Sustained-Release Excipient.
American Association of Pharmaceutical Scientists. 2009:1121-1127.
86.
Olibanum gum, willy Benecke, http://www.wilkey benke.com/olibanum
gum.
87.
Muzib
IY, Kurri P. Formulation and Evaluation of gum olibanum-based
sustained release matrix tablets of ambroxol
hydrochloride. International Journal of Pharmacy and Pharmaceutical Sciences.
2011; 3(2):195-199.
88.
Prasanthi NL, Manikiran SS, Ramarao N. In vitro drug release studies of ziprasidone from tablets using natural gums from biosphere.
Archives of Applied Science Research.
2011; 3(2):513-519.
89.
Chowdary KPR, Mohapatra P, Krishna
MN. Evaluation of olibanum resin as
microencapsulating agent for controlled drug delivery. Rasāyan
journal of chemistry. 2008; 1(1):99-104.
90. Bamiro OA, Sinha VR, Kumar R.
Characterization and evaluation of Terminalia randii gum as a binder in carvedilol
tablet formulation. Acta Pharmaceutica
Sciencia 2010; 52: 254-262.
Received on 16.06.2016 Modified on 11.07.2016
Accepted on 16.07.2016
©A&V Publications All right reserved
Res. J. Pharmacognosy and Phytochem.
2016; 8(3): 145-152.
DOI: 10.5958/0975-4385.2016.00026.1